Hologic (HOLX) Buys Endomag to Boost Breast Cancer Solutions
Hologic (HOLX) acquires Endomag for $310M, enhancing its breast cancer surgery portfolio with innovative technologies like Magseed and Magtrace, aiming to improve patient care and outcomes globally.
Gear Up for Hologic (HOLX) Q3 Earnings: Wall Street Estimates for Key Metrics
Evaluate the expected performance of Hologic (HOLX) for the quarter ended June 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Hologic (HOLX) Advances But Underperforms Market: Key Facts
In the latest trading session, Hologic (HOLX) closed at $78.38, marking a +0.35% move from the previous day.
Hologic's (HOLX) Surgical Business Set to Propel Q3 Earnings
Hologic (HOLX) is likely to have delivered impressive performances across the GYN Surgical and Breast Health businesses in the third quarter of fiscal 2024.
Pre Q3 Earnings: Is Hologic (HOLX) Stock a Portfolio Must-Have?
Hologic (HOLX) benefits from its unique set of businesses, each underpinned by its durable growth drivers. The impressive YTD price rally, earnings prowess and attractive valuation make the stock a top investment pick.
Hologic (HOLX) Exceeds Market Returns: Some Facts to Consider
Hologic (HOLX) closed the most recent trading day at $78.46, moving +1.45% from the previous trading session.
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
HOLX or EW: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Instruments sector might want to consider either Hologic (HOLX) or Edwards Lifesciences (EW). But which of these two stocks offers value investors a better bang for their buck right now?
Hologic (HOLX) Outperforms Broader Market: What You Need to Know
Hologic (HOLX) concluded the recent trading session at $74.53, signifying a +0.58% move from its prior day's close.
Hologic (HOLX) Moves Up 2% in a Week: Time to Consider Buying?
Hologic's (HOLX) fundamental strength and cheaper valuation make it a great new addition to the portfolio.
3 Medical Instruments Picks to Navigate Industry Challenges
Deteriorating geopolitical situation and supply bottlenecks mar the prospects of the Zacks Medical Instruments industry. Yet, HOLX, MASI and VCYT are worth buying based on strategic developments and fundamentals.
Women's Health-Focused Hologic Has Significant Capacity For Expansion Via M&A, Bullish Analyst Says
Stephens initiated coverage on Hologic Inc HOLX, citing it as a major player in women's health, known for its consistent revenue growth, strong free cash flow, and attractive profit margins, is well-positioned in the molecular diagnostics sector post-COVID.
